Last $29.12 USD
Change Today -0.12 / -0.41%
Volume 707.5K
EBS On Other Exchanges
New York
As of 12:51 PM 03/6/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

George A. Joulwan USA (Ret.)

Director and Member of Compensation Committee, Emergent BioSolutions, Inc.
AgeTotal Calculated CompensationThis person is connected to 81 board members in 8 different organizations across 11 different industries.

See Board Relationships


General. George A. Joulwan, USA (Ret), has been the President of One Team Inc. since 1999. General. Joulwan served as Senior Advisor of Global USA Inc. (consulting) from January 1998 to October 1998. He retired from 36 years of service in the military in September 1997 and served as Commander in Chief for the U.S. Army, U.S. Southern Command in Panama from 1990 to 1993. He was the first Supreme Allied Commander Europe to command at every level in the Alliance, from platoon, ...

Read Full Background

Corporate Headquarters*

2273 Research Boulevard
Rockville, Maryland 20850

United States

Phone: 301-795-1800
Fax: 301-795-1899

Board Members Memberships*

Outside Director
Former Director
Former Director, Chairman of Compensation Committee and Member of Nominating & Corporate Governance Committee
Director, Chairman of Special Projects Committee, Member of Governance & Compliance Committee and Member of Compensation Committee
Director and Member of Compensation Committee
Director, Member of Compensation Committee, Member of Compliance Committee and Member of Special Committee
Director and Member of Compensation Committee


Master's Degree
Loyola University of Chicago

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$24,745
Total Calculated Compensation$199,936
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EBS:US $29.12 USD -0.12


Howard W. Robin Chief Executive Officer, President and Director
Nektar Therapeutics
James A. Schoeneck Chief Executive Officer, President and Director
DepoMed Inc.
William S. Marth Chief Executive Officer, President and Director
Albany Molecular Research Inc.
Peter William Grant Chief Executive Officer and Executive Director
Skyepharma PLC
567.0K GBP
Paul Chaplin MSc, Ph.D.Chief Executive Officer and President
Bavarian Nordic A/S
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EMERGENT BIOSOLUTIONS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at